Xcout Intel
SpectraCure competitors & alternatives
The 12 closest competitors and alternatives to SpectraCure among medical devices companies — ranked by similarity to what SpectraCure actually does, not by market-cap band.
Subscribe to see SpectraCure’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About SpectraCure
SpectraCure is a medical technology company that develops a precision treatment system for localized prostate cancer and other internal solid tumors. The company utilizes photodynamic therapy (PDT) combined with a proprietary dose-planning platform to offer targeted, minimally invasive treatments for prostate cancer patients.
SpectraCure at a glance
SpectraCure is a medical devices company headquartered in Sweden, founded in 2003. Xcout tracks 8 named people at SpectraCure, including Jörgen Wennberg (Chairman of the Board).
SpectraCure leadership
- Jörgen WennbergChairman of the Board
- Bernard C BaileyDirector
- Tao TanDirector
- Jesper FreijBoard member
- Masoud KhayyamiBoard member
- Patrik RingblomBoard member
2 more named people on record for SpectraCure, with roles, board committees and tenure — see the full roster →
Top 12 SpectraCure competitors
Ranked by semantic similarity — how close each company is to SpectraCure by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
Alpha Tau Medical is an Israeli medical technology company developing Alpha DaRT, a localized targeted alpha-radiation therapy for treating solid tumors. Its technology is intended for cancer patients and is administered by healthcare providers such as oncologists and hospitals.
Similar medical devices company
Sirtex Medical is a global healthcare company founded in 1997 with its U.S. headquarters in Woburn, Massachusetts. The company specializes in improving patient outcomes, offering products such as SIR-Spheres yttrium-90 microspheres, and maintains offices across the U.S., Australia, Germany, and Singapore.
Similar medical devices company
Eckert & Ziegler SE manufactures and sells isotope technology components in Europe, North America, Asia, and internationally. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds based on iodine-125; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of choroidal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories, X-Ray therapy, GA-68 generators, radiochromatography, hot cells; and radiopharmaceuticals, laboratory equipment, radiosynthesis equipment, quality-control equipment, consumables, therapeutic products and plant engineering, and other services. It offers standard and radiation sources for medical and industrial sectors; medical imaging and spect diagnostics, industrial analytical and instrument, high activity CS-137 and CO-60, and oil well logging sources; blood irradiators and environmental disposal source services; and bulk isotopes as well as calibration-related sources for radioisotopes. In addition, the company offers Tc-99m generators and supplies, trade in raw isotopes and other products, and services. It serves medical, scientific, and industrial applications. The company was formerly known as Eckert & Ziegler Strahlen- und Medizintechnik AG and changed its name to Eckert & Ziegler SE in March 2024. Eckert & Ziegler SE was founded in 1992 and is headquartered in Berlin, Germany.
Medical Device
Focal Therapeutics provides the Focal One robotic system, which utilizes high-intensity focused ultrasound (HIFU) technology to non-invasively target and ablate prostate tissue for prostate cancer patients. The system is designed for urologists to precisely treat targeted lesions while sparing healthy surrounding tissue and minimizing side effects.
Similar medical devices company
Accuray Incorporated designs and manufactures radiotherapy and radiosurgery treatment systems, such as the CyberKnife and Radixact platforms, to deliver precise radiation therapy for cancer care. The company serves clinicians and healthcare providers globally, aiming to expand the curative power of radiation treatment for complex and routine patient needs.
Similar medical devices company
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Medical Device
Focal Medical develops and manufactures the Focal One HIFU Robotic System, a non-invasive medical device that utilizes high-intensity focused ultrasound technology to precisely target and ablate prostate tissue. The company serves urologists and healthcare facilities by providing equipment for prostate cancer management that preserves healthy surrounding tissue and minimizes side effects for patients.
Similar medical devices company
Current Surgical Inc. is developing a digital surgery platform that combines real-time imaging, focused ultrasound, and AI-driven algorithms to provide millimeter-level precision for treating solid tumors and other medical conditions. The platform aims to assist surgeons by enhancing accuracy and reducing risk in minimally invasive procedures across multiple markets such as oncology, cardiology, and neurology.
Similar medical devices company
Accure Acne, Inc. is wholly committed to developing revolutionary solutions to provide a long-lasting, durable response to acne. The company offers a specialized laser treatment option designed for acne care.
Similar medical devices company
MedicaMetrix develops medical devices for prostate health, specifically offering the ProstaMetrix platform to measure prostate volume and calculate Prostate Specific Antigen Density (PSAD) during routine clinical examinations. The company serves urologists and healthcare professionals by providing tools for the early detection and ongoing monitoring of prostate conditions such as prostate cancer and BPH.
Similar medical devices company
3DBiopsy, Inc. operates as a medical device company that develops 3D mapping software, biopsy needles, biopsy actuators, and integrated pathology systems.
Medical - Devices
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of SpectraCure and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for SpectraCureand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →